VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission

Am J Clin Oncol. 1993 Apr;16(2):102-4. doi: 10.1097/00000421-199304000-00003.

Abstract

A complete response with combination chemotherapy was obtained in a patient with metastatic Merkel cell carcinoma. This complete response lasted 15 months. This case report demonstrates the chemosensitivity of this metastatic disease when treated with combination chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Carcinoma, Merkel Cell / drug therapy*
  • Carcinoma, Merkel Cell / secondary
  • Cisplatin / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Skin Neoplasms / drug therapy*

Substances

  • Bleomycin
  • Etoposide
  • Doxorubicin
  • Cisplatin